美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Perpetuals.com Ltd

8.08

+0.20002.54%

盤後：8.080.00000.00%18:26 EDT

成交量：16.52萬

成交額：132.75萬

市值：2,464.86萬

市盈率：-13.55

高：8.20

開：7.90

低：7.63

收：7.88

52周最高：10.50

52周最低：1.64

股本：305.06萬

流通股本：107.11萬

量比：0.85

換手率：15.43%

股息：- -

股息率：- -

每股收益(TTM):-0.5962

每股收益(LYR):-0.5960

淨資產收益率：-126.84%

總資產收益率：-40.12%

市淨率：52.10

市盈率(LYR):-13.56

資料載入中...

總覽公司新聞資訊公告

Perpetuals.com Ltd將Bayesshield AI擴展至醫療領域，直擊診斷錯誤的根源問題

Perpetuals與德國數字科學大學達成合作授權人工智能交易平台

Cellectar Biosciences, Inc.盤中異動大幅下跌7.86%報2.99美元

Cellectar Biosciences, Inc.盤中異動急速下挫5.41%

「3+3+3」模式推進區域中小學科技教育的探索與實踐

中国教育新闻网

Cellectar Biosciences, Inc.盤中異動快速拉升5.26%報3.20美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PDC/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","market":"US","secType":"STK","nameCN":"Perpetuals.com Ltd","latestPrice":8.08,"timestamp":1777579200000,"preClose":7.88,"halted":0,"volume":165248,"hourTrading":{"tag":"盘后","latestPrice":8.08,"preClose":8.08,"latestTime":"18:26 EDT","volume":51,"amount":411.56,"timestamp":1777587968001,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0253807106598985,"floatShares":1071107,"shares":3050570,"eps":-0.596155,"marketStatus":"未開盤","change":0.2,"latestTime":"04-30 16:00:00 EDT","open":7.9,"high":8.2,"low":7.63,"amount":1327483.0403200001,"amplitude":0.072335,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.596155,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1777622400000},"marketStatusCode":0,"adr":0,"adrRate":5,"listingDate":1690257600000,"exchange":"NASDAQ","adjPreClose":7.88,"preHourTrading":{"tag":"盘前","latestPrice":7.93,"preClose":7.88,"latestTime":"09:25 EDT","volume":441,"amount":3511.230093,"timestamp":1777555500057,"change":0.05,"changeRate":0.006345,"amplitude":0.003807},"postHourTrading":{"tag":"盘后","latestPrice":8.08,"preClose":8.08,"latestTime":"18:26 EDT","volume":51,"amount":411.56,"timestamp":1777587968001,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.852821},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","floatShares":1071107,"roa":"-40.12%","roe":"-126.84%","lyrEps":-0.596009,"volumeRatio":0.852821,"shares":3050570,"dividePrice":0,"high":8.2,"amplitude":0.072335,"preClose":7.88,"low":7.63,"week52Low":1.64,"pbRate":"52.10","psRate":"8.76","week52High":10.5,"institutionHeld":0,"latestPrice":8.08,"eps":-0.596155,"divideRate":0,"volume":165248,"delay":0,"ttmEps":-0.596155,"open":7.9,"prevYearClose":6.475,"prevWeekClose":7.16,"prevMonthClose":4.95,"prevQuarterClose":4.95,"fiveDayClose":6.91,"twentyDayClose":4.92,"sixtyDayClose":4.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-16","symbol":"PDC","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDC","date":"2026-04-29","current":-13.553522,"percent":0.014925,"low":-14.928605,"twenty":-10.910743,"median":-9.43043,"eighty":-8.744002,"high":-7.275042,"avg":-9.909347,"sd":1.860387,"marketCap":23153826},"quantilePoints":[{"date":"2026-01-23","current":-12.841505,"twenty":-12.726719,"median":-12.554539,"eighty":-12.382359,"marketCap":20820140},{"date":"2026-01-30","current":-9.396756,"twenty":-12.329049,"median":-11.675543,"eighty":-10.201718,"marketCap":15771446},{"date":"2026-02-06","current":-7.275042,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"marketCap":11897223},{"date":"2026-02-13","current":-8.985188,"twenty":-11.515878,"median":-8.985188,"eighty":-7.549471,"marketCap":15130827},{"date":"2026-02-20","current":-8.855994,"twenty":-10.87722,"median":-8.985188,"eighty":-7.579088,"marketCap":14673241},{"date":"2026-02-27","current":-8.742983,"twenty":-10.032842,"median":-8.830662,"eighty":-7.735212,"marketCap":14368184},{"date":"2026-03-06","current":-9.337263,"twenty":-10.032842,"median":-8.985188,"eighty":-8.021273,"marketCap":15191838},{"date":"2026-03-13","current":-9.688387,"twenty":-9.991079,"median":-9.288813,"eighty":-8.290652,"marketCap":15618918},{"date":"2026-03-20","current":-9.233278,"twenty":-9.991079,"median":-9.314811,"eighty":-8.348912,"marketCap":14993551},{"date":"2026-03-27","current":-9.069316,"twenty":-9.96573,"median":-9.348389,"eighty":-8.474222,"marketCap":14581724},{"date":"2026-04-02","current":-9.313761,"twenty":-9.884139,"median":-9.348389,"eighty":-8.689231,"marketCap":15008804},{"date":"2026-04-10","current":-9.533008,"twenty":-9.74834,"median":-9.359515,"eighty":-8.70742,"marketCap":15374872},{"date":"2026-04-17","current":-12.673274,"twenty":-9.884139,"median":-9.362202,"eighty":-8.546978,"marketCap":20438819},{"date":"2026-04-24","current":-13.088049,"twenty":-10.217704,"median":-9.396756,"eighty":-8.70742,"marketCap":21079438},{"date":"2026-04-29","current":-14.452225,"twenty":-10.910743,"median":-9.43043,"eighty":-8.744002,"marketCap":23153826}],"updateTime":1777616754847},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDC\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1168490458","title":"Perpetuals.com Ltd將Bayesshield AI擴展至醫療領域，直擊診斷錯誤的根源問題","url":"https://stock-news.laohu8.com/highlight/detail?id=1168490458","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168490458?lang=zh_tw&edition=fundamental","pubTime":"2026-04-23 04:30","pubTimestamp":1776889831,"startTime":"0","endTime":"0","summary":"Perpetuals.com Ltd宣布将其人工智能系统Bayesshield的应用范围拓展至医疗健康行业，旨在从根源上解决诊断过程中出现的错误问题。这一战略举措标志着该公司在人工智能技术跨领域应用方面迈出重要一步。此次扩展体现了Perpetuals.com Ltd在人工智能技术创新方面的持续投入，以及该公司致力于通过技术手段解决行业核心挑战的承诺。Bayesshield AI在医疗领域的应用预计将为诊断流程带来革命性改进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175653556","title":"Perpetuals與德國數字科學大學達成合作 授權人工智能交易平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1175653556","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175653556?lang=zh_tw&edition=fundamental","pubTime":"2026-04-16 19:01","pubTimestamp":1776337275,"startTime":"0","endTime":"0","summary":"Perpetuals.com Ltd（简称Perpetuals）近日宣布与德国数字科学大学建立战略合作伙伴关系，双方已签署协议授权该校使用其人工智能交易平台。\n此次合作将推动人工智能技术在金融交易领域的学术研究与实际应用相结合。德国数字科学大学将获得Perpetuals先进AI交易平台的授权使用资格，用于学术研究、教学实验和技术开发。\n这一合作标志着金融科技公司与高等教育机构在人工智能交易技术创新方面的深度协同。通过校企合作模式，双方将共同探索AI在量化交易、风险管理和市场预测等领域的应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616755321","title":"Cellectar Biosciences, Inc.盤中異動 大幅下跌7.86%報2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616755321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616755321?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 01:50","pubTimestamp":1772473800,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日01时50分，Cellectar Biosciences, Inc.股票出现异动，股价急速下挫7.86%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Rallybio Corporation、Anebulo Pharmaceuticals, Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Rallybio Corporation较为活跃，换手率分别为154.43%、92.51%、53.62%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Anebulo Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为53.84%、38.89%、31.86%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603030150009542a753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603030150009542a753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PDC","BK4123","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614867148","title":"Cellectar Biosciences, Inc.盤中異動 急速下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614867148?lang=zh_tw&edition=fundamental","pubTime":"2026-02-28 00:29","pubTimestamp":1772209796,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日00时29分，Cellectar Biosciences, Inc.股票出现异动，股价快速下跌5.41%。截至发稿，该股报3.32美元/股，成交量5520股，换手率0.13%，振幅3.99%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Ensysce Biosciences, Inc.、Edesa Biotech, Inc.、Neurogene Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为6195.78%、555.22%、224.13%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Edesa Biotech, Inc.、Ensysce Biosciences, Inc.，振幅分别为76.88%、60.64%、51.85%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022800295695424d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022800295695424d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4123","PDC","BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610113806","title":"「3+3+3」模式推進區域中小學科技教育的探索與實踐","url":"https://stock-news.laohu8.com/highlight/detail?id=2610113806","media":"中国教育新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610113806?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 15:25","pubTimestamp":1770708300,"startTime":"0","endTime":"0","summary":"2025年10月，教育部等七部门联合印发《关于加强中小学科技教育的意见》，旨在推动科技教育的综合全面发展，培养中小学学生的科学素养、创新精神与实践能力。水磨沟区成立了新疆大学、新疆医科大学、新疆师范大学、中国科学院新疆分院、自治区科技馆、自治区自然博物馆、市“六馆一心”等20余处科技教育实践基地。探索建立“名师工作室+基地校”联动机制，建有水磨沟区中小学科学教育名师工作室1个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tjhz/2026-02-10/doc-inhmihnm8520175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610667714","title":"Cellectar Biosciences, Inc.盤中異動 快速拉升5.26%報3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610667714?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 01:35","pubTimestamp":1770658515,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日01时35分，Cellectar Biosciences, Inc.股票出现异动，股价大幅上涨5.26%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Humacyte, Inc.、Tuhura Biosciences, Inc.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Aim Immunotech Inc.较为活跃，换手率分别为325.30%、181.27%、29.54%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.，振幅分别为59.15%、52.99%、51.63%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210013516a6e6fa5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210013516a6e6fa5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139","BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}